These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11119945)

  • 1. Long-term outcome of living-unrelated donor kidney transplantation.
    Prabhakar KS; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1807-8. PubMed ID: 11119945
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 3. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 4. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
    Tsai MK; Lee PH; Hu RH; Lee CJ
    Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381
    [No Abstract]   [Full Text] [Related]  

  • 5. Kidney transplantation at one center: 1-year results.
    Haberal M; Bilgin N; Karakayali H; Arslan G; Büyükpamukçu N; Velidedeoğlu E; Turan M; Akkoç H; Moray G; Tezel E
    Transplant Proc; 1996 Feb; 28(1):410-1. PubMed ID: 8644295
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of renal transplantation over 20 years after surgery, using azathioprine and low-dose prednisolone as the sole immunosuppression.
    Yoshimura N; Okamoto M; Akioka K; Nakamura K; Ushigome H; Kadotani Y; Nobori S; Higuchi A; Ohmori Y
    Transplant Proc; 2003 Feb; 35(1):143-4. PubMed ID: 12591340
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term graft survival of living-related kidneys after donor-specific transfusion.
    Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Fukunaga K; Seino K; Todoroki T; Fukao K
    Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
    [No Abstract]   [Full Text] [Related]  

  • 8. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
    Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
    Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Lawen J; MacSween M; Kiberd B; West K; McAlister VC
    Transplant Proc; 1997; 29(1-2):190. PubMed ID: 9122958
    [No Abstract]   [Full Text] [Related]  

  • 10. Obese kidney transplant recipients have good outcomes.
    Howard RJ; Thai VB; Patton PR; Hemming AW; Reed AI; Van der Werf WJ; Fujita S; Karlix JL; Scornik JC
    Transplant Proc; 2001; 33(7-8):3420-1. PubMed ID: 11750464
    [No Abstract]   [Full Text] [Related]  

  • 11. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
    Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
    Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
    Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
    Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
    [No Abstract]   [Full Text] [Related]  

  • 13. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
    Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
    Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 15. Transplantation in Singapore.
    Vathsala A; Lee WT; Li MK; Woo KT; Lim CH
    Transplant Proc; 1995 Feb; 27(1):1472-5. PubMed ID: 7878947
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
    Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A; Sasvári I; Toronyi E; Borka P; Lázár N; Járay J; Perner F
    Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.